Related content

Cytochrome P450 Pharmacogenetics in Drug Development: In Vitro Studies and Clinical Consequences

By  

Current Drug Metabolism, Vol. 3, Iss. 3, 2002-06 ,pp. : 289-309

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Cytochrome P450 Polymorphisms in the Development of Pulmonary Drug Toxicity: A Case-Control Study in the Netherlands

By Wijnen Petal A.H.M   Drent Marjolein   Nelemans Patty J.   Kuijpers Petra M.J.C.   Koek Ger H.   Neef Cees   Haenen Guido R.M.M.   Bekers Otto  

Drug Safety, Vol. 31, Iss. 12, 2008-01 ,pp. : 1125-1134

Adis International

Access to resources Recommend Favorite

Cytochrome P450 polymorphisms and drug-induced interstitial lung disease

By Schwaiblmair Martin   Behr Werner   Foerg Wolfgang   Berghaus Thomas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1547-1560

Informa Healthcare

Access to resources Recommend Favorite

Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms

By Ingelman-Sundberg Magnus  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 1, 2004-01 ,pp. : 89-104

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Drugs Undergoing Polymorphic Metabolism by Human Cytochrome P450 2C9 and the Implication in Drug Development

By  

Current Medicinal Chemistry, Vol. 18, Iss. 5, 2011-02 ,pp. : 667-713

Bentham Science Publishers

Access to resources Recommend Favorite